Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa

BACKGROUND: Methods to improve the clinical efficacy of currently available antibiotics against multidrug resistant bacteria in cystic fibrosis (CF) chronic rhinosinusitis (CRS) are greatly needed. Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, was recently identified...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Rhinol Allergy
Glavni autori: Cho, Do-Yeon, Lim, Dong Jin, Mackey, Calvin, Skinner, Daniel, Zhang, Shaoyan, McCormick, Justin, Woodworth, Bradford A.
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2018
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728449/
https://ncbi.nlm.nih.gov/pubmed/30585080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1945892418815615
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items